CBS News @CBSNews
Researchers emphasized the effectiveness of the vaccine among people above 65 years of age and the immunocompromised population, two groups that are more likely to get a severe illness from the flu and less likely to have an immune response to the vaccine. https://t.co/1Zuf5BigD7 — PolitiTweet.org